— AngioDynamics Inc. (NASDAQ: ANGO) reported Q2 2020 earnings of $0.06 per share, vs. $0.02 expected.
— Net sales remained flat at $70 million, vs. $71.2 million expected.
— US net sales grew 1.8% to $55.6 million.
— International net sales increased 5.6% to $14.4 million.
— Oncology net sales rose 5.1% to $16.1 million.
— Vascular Interventions and Therapies net sales grew 0.6% to $31.2 million.
— Vascular Access net sales fell 4% to $22.8 million.
— FY2020 net sales are expected to be $280-286 million.
— FY2020 adjusted EPS is expected to be $0.10-0.15.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
